ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0203

Feasibility and Acceptability of Integrating Patient Reported Outcomes Within Routine Care of Rheumatoid Arthritis

Manisha Verma1, Pragya Singh2, MICHAEL KEITH2, LYNN GERBER2, ROBERT CHAO2, ERICA MCBRIDE2, Yingxue Zhang2, Manirath Srishord2 and ZOBAIR YOUNOSSI2, 1Inova Health System, Wynnewood, PA, 2Inova Health System, Falls Church, VA

Meeting: ACR Convergence 2022

Keywords: Patient reported outcomes, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Advancements in measurement science have demonstrated that patient reported outcomes (PROs) can act as supplements to clinical markers for a comprehensive assessment of disease impact, diagnosis and treatment effectiveness for high burden diseases like Rheumatoid Arthritis (RA). PROs are patient generated data which provide an assessment of the patient’s perception of their function. Though guidelines exist to inform methodological and practical decisions to implement PROs in clinical practices, integrating PROs at the level of individual clinical decision making is currently underdeveloped. We conducted a prospective quality improvement project aiming to integrate PROs within our electronic medical records (EMR, Epic system) for RA patients.

Methods: This is a prospective quality improvement project assessing the feasibility and acceptability of PRO integration within routine RA care. The IRB considered this exempt from human subjects research. We selected two PROs with direct input from Rheumatologists, RAPID-3 and PROMIS-10. Any patient with a diagnosis code of RA who had a scheduled visit with a Rheumatologist was sent an email link to complete these PROs. Patients were able to complete these through the patient portal (MyChart). Once completed, the results auto-populated into the patients’ medical records into a flow-sheet (similar to lab results). The results were available to providers during the clinical consult. Patient’s check out from the clinic triggered an automated message through MyChart to request them to complete a feedback questionnaire (to assess acceptability).

Randomly selected patients were approached for semi-structured interviews to further assess their experiences with use of PROs. All rheumatologists completed a feedback survey and interviews after 6 months of launch of project. Interviews were audio recorded and transcribed for analysis.

Results: 122 patients completed both PROMIS-10 surveys and the RAPID-3 questionnaires. Mean age 58.35 years with >90% females and 48% Caucasians. The mean (SD) RAPID-3 score is 9.726 (5.85) (Figure 1). Mean PROMIS physical function score 41.32 (9.02), and mean PROMIS mental health score 46.54 (8.58)

Mean age of patients who completed feedback questionnaires (n=58) was somewhat higher than those who did not (60. 79 vs 56.48). Figure 2 shows the responses to patient feedback questionnaires. Notably, > 65% patients agreed that PROs helped communicate their current concerns to their doctors. Of the 35 participants who were interviewed, >70% reported PROs were useful to improve their experience and satisfaction with clinical visit. Among the Rheumatologists (n=6), 33% reported PROs increased burden of additional time, while 80% reported PROs provided additional clinically useful information, which helped improve symptom management (Figure 3).

Conclusion: Integrating PROs within routine RA care is feasible and acceptable to both patients and providers. Although there is increased burden on providers for the additional time, the information is clinically useful. Future large-scale efforts need to explore the impact of PRO integration on clinical measures.

Supporting image 1

Patient Reported Outcomes Scores: Box Plots of RAPID_3 (Routine Assessment of Patient Index Data 3) and PROMIS_10 (PROMIS Global Health survey)

Supporting image 2

Patient Feedback Survey (completed after the PRO integrated clinical visits)

Supporting image 3

Qualitative Analyses of patient and provider interviews.


Disclosures: M. Verma, None; P. Singh, None; M. KEITH, None; L. GERBER, None; R. CHAO, None; E. MCBRIDE, None; Y. Zhang, None; M. Srishord, None; Z. YOUNOSSI, None.

To cite this abstract in AMA style:

Verma M, Singh P, KEITH M, GERBER L, CHAO R, MCBRIDE E, Zhang Y, Srishord M, YOUNOSSI Z. Feasibility and Acceptability of Integrating Patient Reported Outcomes Within Routine Care of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/feasibility-and-acceptability-of-integrating-patient-reported-outcomes-within-routine-care-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/feasibility-and-acceptability-of-integrating-patient-reported-outcomes-within-routine-care-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology